Celeris Therapeutics announces the appointment of biotech veterans to lead drug discovery and biology efforts
Hires of Dr. Friedrich Kroll, as VP of Drug Discovery and Dr. Markus Muellner, as VP of Biology reflect ambitions to move quickly into the clinic MENLO PARK, CA, USA, February 2, 2022 /EINPresswire.com/ -- Dr. Friedrich Kroll, who has more than 25 years …